Hugh Walker
Queen's University
10 Papers
107 Citations
Hugh Walker is an academic researcher from Queen's University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 10, co-authored 10 publications. Previous affiliations of Hugh Walker include Kingston General Hospital.
Chat about Author
Papers
An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer.
TL;DR: This method provides a rational starting point for the long-term planning of RT services and for the audit of access to RT at the population level and will be possible to estimate the appropriate RT treatment rate for the cancer population as a whole.
67
Resource use and costs of end-of-Life/palliative care: Ontario adult cancer patients dying during 2002 and 2003.
Hugh Walker,Mark Anderson,Farah Farahati,Doris Howell,S. Lawrence Librach,Amna Husain,Jonathan Sussman,Raymond Viola,Rinku Sutradhar,Lisa Barbera +9 more
TL;DR: The results suggest that acute care consumes 75 percent of EOL/PAL funding and that only a small proportion of health care services used by EOL-PAL care cancer patients is likely to be formal palliative care.
65
To Stimulate or Withdraw? A Cost-Utility Analysis of Recombinant Human Thyrotropin Versus Thyroxine Withdrawal for Radioiodine Ablation in Patients with Low-Risk Differentiated Thyroid Cancer in the United States
TL;DR: In the United States, the cost-effectiveness of rhTSH for ablation in patients with low-risk differentiated thyroid cancer is highly dependent on potential variations in cost of rh TSH, rates of remnant ablation, time off work, and quality of life.
41
Health system characteristics of quality care delivery: a comparative case study examination of palliative care for cancer patients in four regions in Ontario, Canada
Jonathan Sussman,Lisa Barbera,Daryl Bainbridge,Doris Howell,Jinghao Yang,Amna Husain,S. Lawrence Librach,Raymond Viola,Hugh Walker +8 more
TL;DR: Whether a set of modifiable health system factors could be identified that are associated with population palliative care outcomes, including less acute care use and more home deaths, are explored.
35
Estimating the benefit and cost of radiotherapy for lung cancer.
TL;DR: Using RT in the initial management of lung cancer can provide considerable gains in survival and symptom control and the cost of RT is inexpensive compared with a common cut off of $50,000 per life year gained.
23